Boston Scientific (BSX) Shares Fall 3.5% Due to Cyberattack

Boston Scientific (BSX) reported a cyberattack this week disrupting its operations and access to information systems, according to an SEC filing. The attack led to a 3.5% decline in premarket trading. Additionally, shares of the $72 billion medical device maker have nearly halved this year following a weak profit forecast from the first quarter. The company is working to restore affected systems, but a timeline for full restoration remains unclear, impacting investor confidence.